| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
SRA Run Selector
|
Sven Borchmann
|
||||||
| GSE173107 |
Tripartite target-agnostic combination immunotherapy cures established poorly immunogenic tumors
|
160 |
|
Sven Borchmann | Oct 28, 2022 |
